04:31 PM EDT, 09/02/2025 (MT Newswires) -- Mineralys Therapeutics ( MLYS ) launched a public offering of $175 million in common stock.

Underwriters are expected to receive a 30-day option to buy up to an additional $26.25 million at the public offering price, the company said Tuesday in a statement.

Net proceeds will be used partly to fund clinical development of lorundrostat, an experimental treatment for hypertension.

The company's share fell 3.9% in after-hours trading.